2024 annual financial data
Beta Bionics 2024 Operating margin
Beta Bionics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -69.48%.
Operating income was -45,251,000 USD and net income was -54,756,000 USD.
Operating cash flow was -48,273,000 USD.
Get free Beta Bionics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 65,124,000 USD
- Operating income
- -45,251,000 USD
- Net income
- -54,756,000 USD
- Operating cash flow
- -48,273,000 USD